Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2014
08/19/2014US8809528 Quinazolinone derivatives useful as vanilloid antagonists
08/19/2014US8809525 1,2,4-triazine-4-amine derivatives
08/19/2014US8809524 Phenylacetic acid compound
08/19/2014US8809521 Delayed self-gelling alginate systems and uses thereof
08/19/2014US8809520 Phosphonate nucleosides useful as active ingredients in pharmaceutical compositions for the treatment of viral infections, and intermediates for their production
08/19/2014US8809402 Oxazolone and pyrrolidinone-substituted biphenyls as P2X3 and P2X2/3 antagonists
08/19/2014US8809401 Composition with improved skin penetration for transdermal delivery of tolterodine
08/19/2014US8809400 Method to ameliorate oxidative stress and improve working memory via pterostilbene administration
08/19/2014US8809399 Methods of treating gastrointestinal spasms triggered by stress
08/19/2014US8809398 Liquid formulations containing a carotinoid
08/19/2014US8809397 Nicotinic receptor non-competitive antagonists
08/19/2014US8809396 Substituted fused-ring compounds for inflammation and immune-related uses
08/19/2014US8809395 Methods for making valerenic acid derivatives and their use
08/19/2014US8809394 Tranexamic acid formulations
08/19/2014US8809393 Injectable preparations of diclofenac and its pharmaceutically acceptable salts
08/19/2014US8809392 Sulfoperoxycarboxylic acids, their preparation and methods of use as bleaching and antimicrobial agents
08/19/2014US8809391 Agent for treating Parkinson's disease
08/19/2014US8809390 Compound accelerating secretion of human-derived anti-microbial peptide, method for preparing same, and composition having same as active ingredient
08/19/2014US8809388 Vegetable oil composition containing palm mid-fraction fat and method of reducing plasma cholesterol
08/19/2014US8809387 Chroman-derived anti-androgens for treatment of androgen mediated disorders
08/19/2014US8809386 Use of dynamin ring stabilizers
08/19/2014US8809385 Crystalline form of (2S)-(-)-N-(6-chloro-2,3-dihydro-benzo[1,4]dioxin-2-ylmethyl)-sulfamide
08/19/2014US8809384 Azaspirodecanone compounds
08/19/2014US8809383 Pyrazole compound
08/19/2014US8809382 5-oxo-ETE receptor antagonist compounds
08/19/2014US8809381 Highly selective sigma receptor ligands
08/19/2014US8809380 Picolinamide derivatives as TTX-S blockers
08/19/2014US8809379 Selective subtype alpha 2 adrenergic agents and methods for use thereof
08/19/2014US8809378 Metalloenzyme inhibitor compounds
08/19/2014US8809377 Deubiquitinase inhibitors and methods for use of the same
08/19/2014US8809376 Indanyloxydihydrobenzofuranylacetic acids
08/19/2014US8809375 Spot-on pesticide composition
08/19/2014US8809374 Spot-on pesticide composition
08/19/2014US8809373 Pyridine non-classical cannabinoid compounds and related methods of use
08/19/2014US8809372 Pyridine derivatives
08/19/2014US8809370 AMPK-activating heterocyclic compounds and methods for using the same
08/19/2014US8809369 Tetrahydroquinoline derivatives
08/19/2014US8809368 Compounds affecting gap junction activity
08/19/2014US8809367 1-1-Oxo-1,2,3,4-tetrahydroisoquinolin-7-yl)urea derivatives as N-formyl peptide receptor like-1 (FPRL-1) receptor modulators
08/19/2014US8809366 Thienopyridine ester derivative containing cyano group, preparation method, use and composition thereof
08/19/2014US8809365 1-substituted 2-azabicyclo [3.1.1] heptyl derivatives useful as nicotinic acetylcholine receptor modulators for treating neurologic disorders
08/19/2014US8809364 Polycyclic aryl substituted triazoles and polycyclic heteroaryl substituted triazoles useful as axl inhibitors
08/19/2014US8809363 Inhibitors of HIV replication
08/19/2014US8809362 Anticancer agent sensitivity-determining marker
08/19/2014US8809361 2,3-dihydrofuro[2,3-c]pyridines, their use as modulators of the G-protein-coupled receptor GPR119 and pharmaceutical compositions thereof
08/19/2014US8809360 Use of a pyridine compound for the preparation of a medicament for the treatment of skin lesions
08/19/2014US8809359 Phenyl amino pyrimidine bicyclic compounds and uses thereof
08/19/2014US8809358 Use of IκB-kinase inhibitors in pain therapy
08/19/2014US8809357 Compounds and derivatizations of DNAs and RNAs on the nucleobases of pyrimidines for function, structure and therapeutics
08/19/2014US8809355 GABAA receptor modulators
08/19/2014US8809354 3-amino-2-(4-nitrophenyl)-4-(3H)-quinazolinone or derivatives thereof for treating or preventing antiviral infections
08/19/2014US8809353 Quinazolines useful as modulators of voltage gated ion channels
08/19/2014US8809352 Sulfonamides as inhibitors of Bcl-2 family proteins for the treatments of cancer
08/19/2014US8809351 Antiviral compound and cox-2 inhibitor combination therapy for functional somatic syndromes, including combination of famciclovir and celecoxib
08/19/2014US8809350 Purine and pyrimidine CDK inhibitors and their use for the treatment of autoimmune diseases
08/19/2014US8809349 Processes for preparing isoquinolinones and solid forms of isoquinolinones
08/19/2014US8809348 6-arylmethyl substituted pyrazolo[3,4-d]pyrimidines
08/19/2014US8809347 Bicyclic aryl and bicyclic heteroaryl substituted triazoles useful as AXL inhibitors
08/19/2014US8809346 ANT-ligands molecules and biological applications
08/19/2014US8809345 6-cycloalkyl-pyrazolopyrimidinones for the treatment of CNS disorders
08/19/2014US8809344 Compounds, compositions, and methods for control of hepatitis C viral infections
08/19/2014US8809343 Pyrimidine derivative, preparation method and use thereof
08/19/2014US8809342 Glucagon receptor modulators
08/19/2014US8809341 2,4-pyrimidinediamine compounds and uses as anti-proliferative agents
08/19/2014US8809340 Crystalline form
08/19/2014US8809339 Compounds and methods for inhibiting phosphate transport
08/19/2014US8809338 1,2,3-triazole-based peptidomimetic integrin inhibitors for the diagnosis and therapy of tumors
08/19/2014US8809337 Carbamoyl derivatives of bicyclic carbonylamino-pyrazoles as prodrugs
08/19/2014US8809336 Ortho-condensed pyridine and pyrimidine derivatives (e.g., purines) as protein kinases inhibitors
08/19/2014US8809335 Pyrazolopyrimidine kinase inhibitors
08/19/2014US8809334 Therapeutic compositions containing macitentan
08/19/2014US8809333 Imidazole, pyrazole, and triazole derivatives useful as antibacterial agents
08/19/2014US8809332 Method for treating anxiety with a dosage form of besylate salts of zopiclone or eszopiclone
08/19/2014US8809331 Aminopyrimidine derivatives as LRRK2 modulators
08/19/2014US8809329 Detection and treatment of schizophrenia
08/19/2014US8809328 Imidazole derivative
08/19/2014US8809327 Sulfonamides as TRPM8 modulators
08/19/2014US8809326 Isoquinolinone Rho kinase inhibitors
08/19/2014US8809325 Benzyl-oxathiazine derivatives substituted with adamantane and noradamantane, medicaments containing said compounds and use thereof
08/19/2014US8809324 Substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof
08/19/2014US8809323 Therapeutic applications of pro-apoptotic benzodiazepines
08/19/2014US8809322 Methods and compositions for the delivery of a therapeutic agent
08/19/2014US8809321 Diaryl ether linked pyrrolo [2,1-c][1,4] benzodiazepine hybrids and process for the preparation thereof
08/19/2014US8809320 Benzodiazepine derivatives
08/19/2014US8809319 Substituted 8-oxa-10,11-dihydroimidazo[2,3-a]bicyclo[3.2.1]oct-3-enes and use thereof as an insecticide
08/19/2014US8809318 Gamma secretase modulators
08/19/2014US8809317 Antiviral compounds
08/19/2014US8809316 Use of immunosuppressant compounds in a new indication
08/19/2014US8809315 Combination medicaments for treating bacterial infections
08/19/2014US8809314 Cephalosporin compound
08/19/2014US8809313 Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating HCV infections
08/19/2014US8809312 Composition and method for affecting obesity and related conditions
08/19/2014US8809311 Nutritional supplements
08/19/2014US8809308 Enema composition for treatment of ulcerative colitis having long term stability
08/19/2014US8809307 Pharmaceutical formulations containing corticosteroids for topical administration
08/19/2014US8809306 Combination andolast/glucocorticoids
08/19/2014US8809305 Administration of adapalene and benzoyl peroxide for the long-term treatment of acne vulgaris
08/19/2014US8809304 Amine compound and use thereof for medical purposes
08/19/2014US8809303 Methods of regulating actin cytoskeletal rearrangement and intercellular gap formation
08/19/2014US8809302 Therapeutic approaches for treating alzheimer'S disease